2024. Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab. Dermatology Practical & Conceptual. 14, 3 (Jul. 2024), e2024171. DOI:https://doi.org/10.5826/dpc.1403a171.